Diagnostics for antiphospholipid syndrome following early-onset fetal growth restriction: A retrospective cohort study.

Philippi, Daphne N; Van de Meent, Mette; Haitjema, Saskia; Limper, Maarten; Lely, Titia; Bloemenkamp, Kitty; Kooiman, Judith

This document is a letter published in the journal Lupus. It discusses the importance of screening for antiphospholipid syndrome (APS) in women who have experienced early-onset fetal growth restriction (FGR) during pregnancy. The study found that APS screening is often not discussed during follow-up visits, despite the potential benefits of treatment with low-molecular-weight-heparin and aspirin in subsequent pregnancies. The study also calculated the incidence of APS among women who were screened and found a prevalence of 7.4%. The authors suggest that implementing standardized protocols for APS diagnostics postpartum could improve screening rates and subsequent pregnancy outcomes.

MISCARRIAGE; FETAL growth retardation; PREGNANCY outcomes; VENOUS thrombosis; POSTNATAL care; ANTIPHOSPHOLIPID syndrome

Lupus, 2024, Vol 33, Issue 11, p1274

0961-2033

Academic Journal

10.1177/09612033241273015